Division of Medical Ethics | NYU Langone Health

Skip to Main Content
Division of Medical Ethics

Division of Medical Ethics

In the Division of Medical Ethics, part of NYU Langone Health’s Department of Population Health, we work to ensure that patients are treated justly and humanely by addressing the moral and practical issues in all aspects of healthcare and biotechnology. The division was founded by bioethicist Arthur L. Caplan, PhD, in 2012. We aim to influence policy, foster careers in bioethics, and educate the wider community about ethical issues in healthcare through research and scholarship.

In our research, we study a variety of bioethics issues: ethical treatment of patients, access to investigational medical products, clinical trial design, vaccine ethics and policy, transplant ethics, gender affirmation, sports and society, research ethics and integrity, end-of-life care and physician-assisted death, and scarce-resource rationing. We frequently share our findings and expertise with the media to advance the general public’s knowledge of medical ethics.

We provide medical ethics education in curricula at NYU School of Medicine and NYU College of Global Public Health and through our High School Bioethics program.

We offer educational opportunities for scholars at all stages of their medical ethics careers, through a visiting scholar program, postdoctoral research fellowships, and internships for high school and college students.

Our Partners

We partner with several groups across NYU and NYU Langone including the NYU Center for Bioethics, NYU Sports and Society Program, and Division of Medical Humanities.

Contact Us

For inquiries about the Division of Medical Ethics, please contact Jessica Wico, program manager, at jessica.wico@nyulangone.org, or 646-501-2739.

Working Group on Compassionate Use and Preapproval Access

We raise awareness and make recommendations about ethical issues around access to investigational products.

News

Forming a Fair, Ethical Process for Patient Access to Investigational Drugs

Read More
Read more: Forming a Fair, Ethical Process for Patient Access to Investigational Drugs